Sanofi Ventures

Investor type

CVC

Founded

2004

AUM

-

Location

United States

Investment Ticket

$1-5 m

Investment Stage

Seed Series A

Region of investment

North America Europe
Investor profile last updated: 08 December, 2021

Profile

Who we are
We are investors in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

What we do
We act similarly to institutional venture capitalists; we have the ability to lead, co-lead, or seed companies. We partner with management on their boards and make equity investments.

Our raison d'être
We provide a low-cost, self-sustaining vehicle enabling our parent company to engage with the early stage innovation ecosystem when companies are too risky or early to in-license or acquire.

We invest in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and radically transforming the healthcare ecosystem.

Our venture model serves as an "innovation front door" to Sanofi. We seek to accelerate all strategic focus areas while reaching into novel and emerging areas of science and technology.

Here are some of the areas that we currently are thinking about:

Rare diseases
Immunology and inflammation
Oncology
Cell and gene therapy
Vaccines
Digital health and data science solutions
We can't do it alone - we would love to hear how you can partner with us to change the healthcare world!

Industry

Healthcare Services Marketing and Advertising HealthTech Biotechnology Medical Devices Life Sciences

Contacts

Name
Title
Email
avatar
Laia Crespo Head of Investments
Head of Investments
-
avatar
Cris De Luca Global Head of Digital Investments
Global Head of Digital Investments
-
Upgrade to see contacts
avatar
3uJHotz1TEeqgAac 3uJHotz1TEeqgAac
3uJHotz1TEeqgAac
avatar
3uJHotz1TEeqgAac 3uJHotz1TEeqgAac
3uJHotz1TEeqgAac
avatar
3uJHotz1TEeqgAac 3uJHotz1TEeqgAac
3uJHotz1TEeqgAac
Investment-team contacts for Sanofi Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sanofi Ventures

Sanofi Ventures operates as a corporate VC (CVC). It backs companies at Seed and Series A, writing tickets of $1-5 m.
Sanofi Ventures is located in United States.
Sanofi Ventures was founded in 2004.
Sanofi Ventures invests in companies and startups in Healthcare Services, Marketing and Advertising, HealthTech, Biotechnology, Medical Devices, Life Sciences.
Sanofi Ventures invests in companies and startups in North America, Europe.
Sanofi Ventures invests in companies and startups at Seed, Series A.
Sanofi Ventures usually invests $1-5 m on average.
Sanofi Ventures can be reached through its website sanofiventures.com, its LinkedIn page and its X account. Its general enquiries address is -. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sanofi Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sanofi Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 08 December, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.